Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

315 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Intravitreal bevacizumab versus triamcinolone acetonide for refractory uveitic cystoid macular edema: a randomized pilot study.
Soheilian M, Rabbanikhah Z, Ramezani A, Kiavash V, Yaseri M, Peyman GA. Soheilian M, et al. Among authors: ramezani a. J Ocul Pharmacol Ther. 2010 Apr;26(2):199-206. doi: 10.1089/jop.2009.0093. J Ocul Pharmacol Ther. 2010. PMID: 20307215 Clinical Trial.
A significant central macular thickness (CMT) reduction was observed only in the IVT group at week 36 (74.6 + or - 108.0 microm [P = 0.049]). ...Irrespective of triamcinolone-induced cataract, a more beneficial effect of IVT may be attainable....
A significant central macular thickness (CMT) reduction was observed only in the IVT group at week 36 (74.6 + or - 108.0 microm [P =
Intravitreal triamcinolone for acute central retinal vein occlusion; a randomized clinical trial.
Ramezani A, Entezari M, Moradian S, Tabatabaei H, Kadkhodaei S. Ramezani A, et al. Graefes Arch Clin Exp Ophthalmol. 2006 Dec;244(12):1601-6. doi: 10.1007/s00417-006-0348-9. Graefes Arch Clin Exp Ophthalmol. 2006. PMID: 16738858 Clinical Trial.
METHODS: In a randomized sham-controlled clinical trial, 27 eyes with recent onset (less than 2 months) CRVO were randomly assigned to two groups. The treatment group (13 eyes) received 4 mg IVT and the control group (14 eyes) received a sham subconjunctival injecti …
METHODS: In a randomized sham-controlled clinical trial, 27 eyes with recent onset (less than 2 months) CRVO were randomly assigned t …
Intravitreal triamcinolone reinjection for refractory diabetic macular edema.
Ramezani A, Ahmadieh H, Tabatabaei H. Ramezani A, et al. Korean J Ophthalmol. 2006 Sep;20(3):156-61. doi: 10.3341/kjo.2006.20.3.156. Korean J Ophthalmol. 2006. PMID: 17004629 Free PMC article. Clinical Trial.
METHODS: In a prospective interventional case series, all IVT treated patients enrolled in a previous clinical trial were recalled to have a new ophthalmologic examination and optical coherence tomography (OCT) performed. ...Visual acuity (VA) changes were no …
METHODS: In a prospective interventional case series, all IVT treated patients enrolled in a previous clinical trial were reca …
A randomized, placebo-controlled clinical trial of intravitreal triamcinolone for refractory diabetic macular edema.
Dehghan MH, Ahmadieh H, Ramezani A, Entezari M, Anisian A. Dehghan MH, et al. Among authors: ramezani a. Int Ophthalmol. 2008 Feb;28(1):7-17. doi: 10.1007/s10792-007-9097-y. Epub 2007 Jun 23. Int Ophthalmol. 2008. PMID: 17589809 Clinical Trial.
METHODS: In a prospective, placebo-controlled, randomized clinical trial, 88 eyes of 61 patients with clinically significant macular edema that would have responded unfavourably to laser photocoagulation were randomly assigned to two groups. The treatment group (45 eyes) r …
METHODS: In a prospective, placebo-controlled, randomized clinical trial, 88 eyes of 61 patients with clinically significant macular …
Diabetic macular edema before and after intravitreal triamcinolone injection.
Ramezani A, Tabatabaie H, Ahmadieh H. Ramezani A, et al. Korean J Ophthalmol. 2007 Jun;21(2):95-9. doi: 10.3341/kjo.2007.21.2.95. Korean J Ophthalmol. 2007. PMID: 17592240 Free PMC article. Clinical Trial.
METHODS: In a prospective interventional case series, twenty five eyes with refractory DME which had been allocated to the sham group of a previous clinical trial underwent new examination and optical coherence tomography about 9 months after their first enrollment. …
METHODS: In a prospective interventional case series, twenty five eyes with refractory DME which had been allocated to the sham group …
Lateral rectus resection versus medial rectus re-recession for residual esotropia: early results of a randomized clinical trial.
Rajavi Z, Ghadim HM, Ramezani A, Azemati M, Daneshvar F. Rajavi Z, et al. Among authors: ramezani a. Clin Exp Ophthalmol. 2007 Aug;35(6):520-6. doi: 10.1111/j.1442-9071.2007.01548.x. Clin Exp Ophthalmol. 2007. PMID: 17760633 Clinical Trial.
Major intraoperative and postoperative complications, including overcorrection and slippage or a lost muscle, did not occur in any of the patients. CONCLUSIONS: Medial rectus muscle re-recession can be a substitute for lateral rectus muscle resection in patients wit …
Major intraoperative and postoperative complications, including overcorrection and slippage or a lost muscle, did not occur in any of …
Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial.
Ahmadieh H, Ramezani A, Shoeibi N, Bijanzadeh B, Tabatabaei A, Azarmina M, Soheilian M, Keshavarzi G, Mohebbi MR. Ahmadieh H, et al. Among authors: ramezani a. Graefes Arch Clin Exp Ophthalmol. 2008 Apr;246(4):483-9. doi: 10.1007/s00417-007-0688-0. Epub 2007 Oct 5. Graefes Arch Clin Exp Ophthalmol. 2008. PMID: 17917738 Clinical Trial.
There was a significant difference between the IVB and control groups (P = 0.012) and between the IVB/IVT and control groups (P = 0.022). ...CONCLUSION: Three consecutive intravitreal injections of bevacizumab had a beneficial effect on refractory DME in terms of CM …
There was a significant difference between the IVB and control groups (P = 0.012) and between the IVB/IVT and control groups (P = 0.0 …
Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.
Soheilian M, Ramezani A, Bijanzadeh B, Yaseri M, Ahmadieh H, Dehghan MH, Azarmina M, Moradian S, Tabatabaei H, Peyman GA. Soheilian M, et al. Among authors: ramezani a. Retina. 2007 Nov-Dec;27(9):1187-95. doi: 10.1097/IAE.0b013e31815ec261. Retina. 2007. PMID: 18046223 Clinical Trial.
PURPOSE: To report the efficacy of a single intravitreal bevacizumab injection alone or in combination with intravitreal triamcinolone acetonide versus macular laser photocoagulation (MPC) as primary treatment of diabetic macular edema (DME). ...CONCLUSION: Up to 12 weeks, …
PURPOSE: To report the efficacy of a single intravitreal bevacizumab injection alone or in combination with intravitreal triamcinolon …
Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial.
Ahmadieh H, Feghhi M, Tabatabaei H, Shoeibi N, Ramezani A, Mohebbi MR. Ahmadieh H, et al. Among authors: ramezani a. Ophthalmology. 2008 Nov;115(11):1938-43. doi: 10.1016/j.ophtha.2008.05.016. Epub 2008 Jun 26. Ophthalmology. 2008. PMID: 18584876 Clinical Trial.
Clinical features and surgical outcomes of pediatric rhegmatogenous retinal detachment.
Soheilian M, Ramezani A, Malihi M, Yaseri M, Ahmadieh H, Dehghan MH, Azarmina M, Moradian S, Peyman GA. Soheilian M, et al. Among authors: ramezani a. Retina. 2009 Apr;29(4):545-51. doi: 10.1097/IAE.0b013e318194fd1a. Retina. 2009. PMID: 19174726
315 results
Jump to page
Feedback